2023-01-24 06:30:00

Nicox to Participate in Financial, Pharmaceutical Industry and Scientific Events in H1 2023

Logo GlobeNewswire
Press Release
Nicox to Participate in Financial, Pharmaceutical Industry and Scientific Events in H1 2023

January 24, 2023 release at 7:30 am CET
Sophia Antipolis, France

Nicox SA (Euronext Paris: FR0013018124, COX), an international ophthalmology company, today that members of the management team will participate in the following financial, pharmaceutical industry and scientific conferences in Europe and U.S. in the coming months:

Financial and Pharmaceutical Industry conferences

Members of the management team will be available for one-on-one meetings at these events.

Scientific conferences

About Nicox
Nicox SA is an international ophthalmology company developing innovative solutions to help maintain vision and improve ocular health. Nicoxs lead program in clinical development is NCX 470, a novel nitric oxide-donating bimatoprost, for lowering intraocular pressure in patients with open-angle glaucoma or ocular hypertension. The company is also conducting research on NCX 1728, a nitric oxide-donating phosphodiesterase 5 inhibitor, in retinal conditions. NCX 4251, a novel, patented, ophthalmic suspension of fluticasone propionate nanocrystals for topical ocular application for dry eye disease, is being developed by Ocumension Therapeutics in China under an exclusive license agreement and is available for partnering elsewhere. Nicox generates revenue from VYZULTA in glaucoma, licensed exclusively worldwide to Bausch + Lomb, and ZERVIATE in allergic conjunctivitis, licensed in multiple geographies, including to Eyevance Pharmaceuticals, LLC (a wholly-owned subsidiary of Santen Pharmaceutical Co., Ltd.), in the U.S. and Ocumension Therapeutics in the Chinese and in the majority of Southeast Asian markets.

Nicox is headquartered in Sophia Antipolis, France, is listed on Euronext Paris (Compartment C: Mid Caps; Ticker symbol: COX) and is part of the CAC Healthcare, CAC Pharma & Bio and Next 150 indexes.

For more information on Nicox, its products or pipeline, please visit: www.nicox.com.
Analyst coverage

Bryan, Garnier & Co Eric YooParis, France
Edison Investment ResearchPooya HemamiLondon, UK
H.C. Wainwright & CoYi ChenNew York, U.S.
Kepler CheuvreuxArsene GuekamParis, France
The views expressed by analysts in their coverage of Nicox are those of the author and do not reflect the views of Nicox. Additionally, the information contained in their reports may not be correct or current. Nicox disavows any obligation to correct or to update the information contained in analyst reports.


Gavin Spencer
Executive Vice President, Chief Business Officer
& Head of Corporate Development
T +33 (0)4 97 24 53 00

Investors & Media
United States & Europe
LifeSci Advisors, LLC
Sandya von der Weid
T +41 78 680 05 38
Forward-Looking Statements
The information contained in this document may be modified without prior notice. This information includes forward-looking statements. Such forward-looking statements are not guarantees of future performance. These statements are based on current expectations or beliefs of the management of Nicox S.A. and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Nicox S.A. and its affiliates, directors, officers, employees, advisers or agents, do not undertake, nor do they have any obligation, to provide updates or to revise any forward-looking statements.

Risks factors which are likely to have a material effect on Nicoxs business are presented in the 3rd chapter of the Document denregistrement universel, rapport financier annuel et rapport de gestion 2021 filed with the French Autorit des Marchs Financiers (AMF) on April 29, 2022 whose first amendment has been filed with the AMF on May 19, 2022, in the 2nd chapter of the second amendment filed with the AMF on November 22, 2022 and in the 2nd chapter of the Securities noted filed with the AMF on November 22, 2022 which are available on Nicoxs website (www.nicox.com)
Nicox S.A.
Drakkar 2
Bt D, 2405 route des Dolines
06560 Valbonne, France
T +33 (0)4 97 24 53 00
F +33 (0)4 97 24 53 99


Continue read on globenewswire.com

Logo GlobeNewswire
SciencePress Release2023-01-18 06:30:00
Press Release Nicox Provides Fourth Quarter 2022 Financial Highlights Net revenue 1. 0 million for fourth quarter 2022, and 3. 3 million for the full year...

Logo EIN Presswire
HealthPress Release2023-01-23 11:00:00
The event will take place on the days of February 1st-3rd at the Paris Hotel in Las Vegas, Nevada. MIAMI, FL, UNITED STATES, January 23, 2023 /...

Logo GlobeNewswire
TechnologyPress Release2023-01-23 16:01:00
Subject matter experts from QuisLex will share their knowledge in upcoming legal forums, company to sponsor key legal and financial industry events NEW YORK,...

Logo GlobeNewswire
SciencePress Release2023-01-23 14:22:00
NEW HAVEN, Conn., Jan. 23, 2023 (GLOBE NEWSWIRE) -- BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI) (the Company or Bioasis ), a multi-asset rare and...

Logo GlobeNewswire
HealthPress Release2023-01-23 21:30:00
DELRAY BEACH, Fla., Jan. 23, 2023 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (PETS) (the Company), Your Trusted Pet Health Expertwill hold a conference call on...

Logo NewsFileCorp
Press Release2023-01-23 13:00:00
Vancouver, British Columbia--(Newsfile Corp. - January 23, 2023) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (" Telescope " or the " Company "),...

Logo PR Newswire
NEW YORK, Jan. 23, 2023 /PRNewswire/ -- The global nicotine gum market size is estimated to increase by USD 1.01 billion from 2020 to 2025. However, the...

Logo GlobeNewswire
SciencePress Release2023-01-23 12:30:00
LEXINGTON, Mass., Jan. 23, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (iSpecimen or the Company), an online global marketplace that connects...

Logo Benzinga
Business / FinanceBy Business Wire2023-01-23 14:36:00
AM Best is sponsoring the ReFocus 2023 conference, an annual insurance industry event co-hosted by the American Council of Life Insurers (ACLI) and the...

Logo PR Newswire
DUBLIN, Jan. 23, 2023 /PRNewswire/ -- The "Genomics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Products...

Logo Nasdaq
Business / Finance2023-01-23 21:00:00
The following companies are expected to report earnings prior to market open on 01/24/2023. Visit our Earnings Calendar for a full list of expected earnings...

Logo PR Newswire
HealthPress Release2023-01-23 12:00:00
DALLAS, Jan. 23, 2023 /PRNewswire/ -- Nanoscope Therapeutics Inc., a clinical-stage biotechnology company developing gene therapies for retinal degenerative...

Logo GlobeNewswire
TechnologyPress Release2023-01-23 22:00:00
CLEVELAND, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Parker Hannifin Corporation (NYSE: PH), the global leader in motion and control technologies, today announced...

Logo PR Newswire
SHENZHEN, China, Jan. 23, 2023 /PRNewswire/ -- Syntech, a leading brand of electronic accessories market, showcased its latest offerings and announced its...

Logo PR Newswire
TechnologyPress Release2023-01-23 08:30:00
SHENZHEN, China, Jan. 23, 2023 /PRNewswire/ -- METZ Display, a sub-brand of Skyworth that specialized in the interactive all-in-one display has announced its...

Logo PR Newswire
HealthPress Release2023-01-23 13:05:00
The global intrathecal drug delivery system market is expected to witness significant growth by 2026, due to the increasing prevalence of cancer worldwide....

Logo PR Newswire
HealthPress Release2023-01-23 13:40:00
DUBLIN, Jan. 23, 2023 /PRNewswire/ -- The "Preclinical Imaging Market Research Report by Product (Modalities and Reagents), Application, End-User, Region -...

Logo Benzinga
Business / FinanceBy Benzinga Insights2023-01-23 21:30:11
Chevron CVX will host a conference call at 11:00 AM ET on January 27, 2023, to discuss Q4 2022 earnings results. How to Attend Chevron (CVX) Conference Call...

Logo PR Newswire
HealthPress Release2023-01-23 11:40:00
DUBLIN, Jan. 23, 2023 /PRNewswire/ -- The "Antibiotics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has...

Logo EIN Presswire
HealthPress Release2023-01-23 13:48:14
Emergen Research Logo Increasing demand for safe and easy-to-use medication distribution devices & attempts by healthcare providers to reduce human...